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 INTRODUCTION 
 
             Supraglottic airway devices have become a standard fixture in airway 
management filling a niche between the face mask and tracheal tube in terms of 
both anatomical position and degree of invasiveness. These devices sit outside 
the trachea but provide a hands free means of achieving a gas tight airway.  
 
            Originally created as hands free replacement for the face mask, the LMA 
has gone on to replace endotracheal tubes as the preferred airway in millions of 
cases each year. This remarkable shift has occurred for number of reasons 
including ease of placement, lower drug requirement, reduced hemodynamic 
response, smoother emergence and lower incidence of sore throat. 
 
           Though LMA provided all the above advantages, the risk of gastric 
distension, pulmonary aspiration of gastric contents and fear of inadequate 
ventilation acted as a deterrent to the widespread use of LMA. 
 
            To overcome the above complications Dr. Archie Brain designed the 
new airway device, LMA – Supreme in 2007, with the modifications to separate 
the respiratory and gastro intestinal tract. It represents the most advanced 
laryngeal airway yet developed by Archie Brain, the inventor of original LMA 
airway, the LMA Classic. 
            Laparoscopic surgery or more appropriately minimal access surgery is 
well established since last two decades. General anaesthesia with controlled 
ventilation remains the gold standard technique for laparoscopic surgeries.      
 
            The ETT has been proved to be a reliable method of securing the airway 
and is considered the standard of care for protecting the airway from aspiration. 
They carry an inherent risk of patient trauma, from vocal cord injury to 
pharyngeal soft tissue injury and also produces hemodynamic responses to rigid 
laryngoscopy.            
 
           Because of ease on insertion and reduced trauma, LMA airways have 
replaced ETT in many procedures. With its integrated gastric tube and verifiable 
placement, the LMA Supreme is an even more effective alternative.     
        
           LMA Supreme is a new airway device that combines the different 
features of its predecessors. It is curved like the LMA-Fastrach, it offers gastric 
access like LMA- Proseal and it is of single use like LMA- Unique. 
 
           The LMA-Supreme forms two seals: an effective first seal with the 
oropharynx (oropharyngeal seal) and an innovative second seal with the upper 
oesophageal sphincter (the oesophageal seal). The optimised distal tip with 
gastric access functionally separates the digestive and respiratory tracts thus 
effectively protecting against regurgitation and gastric distension.  
 
       
        With this background this study was conceptualized to compare the 
performance of LMA- Supreme and Endotracheal tube in elective laparoscopic 
gynaecological surgeries. 
 
 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  STRUCTURE AND FUNCTION OF THE UPPER AIRWAYS 
 
Anatomically airway is the passage through which the air passes during 
respiration. It may be divided into upper and lower airway. The upper airway 
comprises nasal cavity, oral cavity, nasopharynx, oropharynx, pharynx and 
larynx. 
 
Nasal cavity: 
Nasal cavity extends from naris to end of the turbinates. The normal airway 
begins functionally at the nares. As air passes through the nose, the important 
functions of warming and humidification occur. The nose is the primary 
pathway for normal breathing. The nasal cavities are divided by nasal septum. 
The roof is formed by cribriform plate of the ethmoid bone. The bony lateral 
wall is the origin of the three bony turbinates that project into the nasal cavity. 
Openings in the lateral wall communicate with paranasal sinuses. 
 
Oral cavity: 
It extends from mouth opening to anterior tonsillar pillar
21
. Contracture of 
mouth and lips can lead to difficult laryngoscopy. The roof of the mouth is 
bounded by alveolar arch and teeth and consists of the hard palate anteriorly and 
soft palate posteriorly. The tongue makes up the most of the mouth, which is 
bounded by the mandible and teeth. The ability to achieve good mouth opening 
is important for many airway procedures. Initial mouth opening is achieved by 
rotation within the temporomandibular joint and subsequent opening by sliding 
of the condyles of the mandible within the joint. 
 
Pharynx
5
: 
The pharynx is a fibromuscular tube that extends from the base of the skull to 
the lower border of cricoid cartilage. It joins the nasal and oral cavities above; 
with larynx and esophagus below. It is divided into nasopharynx and 
oropharynx. 
 
The nasopharynx: 
Extends from the posterior end of turbinates to posterior pharyngeal wall above 
the soft palate and consists of the nasal cavity, septum, turbinates and adenoids. 
 
The oropharynx: 
Extends from the soft palate above to epiglottis below; and anteriorly from 
tonsillar pillar to posterior pharyngeal wall. It includes the tonsils, uvula and the 
epiglottis. The tongue is the principal source of oropharyngeal obstruction, 
usually because of decreased tone of the genioglossus muscle. The latter 
contracts to move the tongue forward during inspiration and thus act as a 
pharyngeal dilator. The vallecula is the space between epiglottis and base of the 
tongue. It has paired depressions on both sides of glosso epiglottic fold. 
Laryngoscope blade tip is positioned in vallecula during conventional 
laryngoscopy. Gentle upward pressure on the vallecula with laryngoscope blade 
tensions hyoepiglottic ligament and indirectly elevates the larynx and helps in 
the alignment of laryngeal and pharyngeal axes. 
 Larynx: 
The larynx, which lies at the level of the third through sixth cervical vertebrae, 
serves as the organ of phonation and acts as a valve to protect the lower airways 
from the contents of the alimentary tract. 
 
The laryngeal cavity extends from the epiglottis to the lower level of the cricoid 
cartilage. The larynx bulges posteriorly into the laryngopharynx, with the 
pyriform fossa lying on each side. It is suspended from the hyoid bone by the 
thyrohyoid membrane. 
 
The structure consists of muscles, ligaments, and a framework of cartilages. 
These include the thyroid, cricoid, arytenoids, corniculates, and the epiglottis. 
The latter, a fibrous cartilage, has a mucous membrane covering that reflects as 
the glossoepiglottic fold onto the pharyngeal surface of the tongue. The 
epiglottis projects into the pharynx and overhangs the laryngeal inlet. However, 
it is not absolutely essential for sealing off the airway during swallowing.  
 
The inlet is formed by the epiglottis, which joins to the apex of the arytenoid 
cartilages on each side by the aryepiglottic folds. Inside the laryngeal cavity one 
first encounters the vestibular folds, which are narrow bands of fibrous tissue on 
each side. These extend from the anterolateral surface of each arytenoid to the 
angle of the thyroid where the latter attaches to the epiglottis. These folds are 
referred to as the false vocal cords and are separated from the true vocal cords 
by the laryngeal sinus or ventricle. 
 The true vocal cords are pale white ligamentous structures that attach to the 
angles of the thyroid anteriorly and to the arytenoids posteriorly. The triangular 
fissure between these vocal cords is termed the glottic opening, which 
represents the narrowest segment of the laryngeal opening in adults. 
 
Cricoid cartilage is a complete ring shaped cartilage and continues with trachea. 
In young children (<10 years old), the narrowest segment lies just below the 
cords at the level of the cricoid ring.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 LMA – SUPREME 
 
          The laryngeal mask airway Supreme
7, 15
 was designed and developed by 
Dr.Archie Brain in 2007, with primary goal to construct a laryngeal mask with 
improved ventilatory characteristics that also offered protection against 
regurgitation and gastric insufflations. It is a single use disposable airway 
device thus alleviating concerns of cross contamination.  
 
DEVICE DESCRIPTION: 
The LMA- Supreme is a innovative, sterile, single use, latex free supraglottic 
airway management device. It has following components, 
1. Inflatable cuff with interlocking proximal and distal segments 
2. Cuff inflation line with pilot balloon 
3. Airway tube 
4. Drain tube 
5. Integral bite block 
6. Fixation tab 
7. A rigid molded proximal component which forms separate airway and 
drain tube ports. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The LMA – Supreme is considered as an evolution in the design of LMA. The 
special features are, 
 
MASK: 
 Elongated cuff 
It provides improved anatomical fit and support to the effective first and 
the second seal. 
The reinforced tip and molded distal cuff resists folding. 
 
 First seal 
It forms an effective first seal with the oropharynx – oropharyngeal seal. 
It helps to deliver a measured oropharyngeal leak pressures upto 37 cm 
H2O, for high ventilation performance. 
The first seal is considered to be important for: 
 Procedures requiring increased airway pressure during mechanical 
ventilation (e.g. laparoscopic surgeries) 
 Patients requiring increased airway pressure such as morbidly 
obese patients. 
 
 Second seal 
It forms an innovative second seal with the upper oesophageal sphincter-  
oesophageal seal. It separates alimentary tract from respiratory tract.  
The second seal is considered to be important for: 
 Controlling the LMA Supreme tip position 
 Reducing the risk of gastric gas insufflations during ventilation 
  Cuff bowl 
The patented epiglottic fins and the drain tube are positioned in the bowl. 
It prevents the epiglottic occlusion of the airway tube. 
With the cuff deflated, the thin wedge shape of the LMA Supreme feels 
smooth enough to allow comfortable insertion even in patients with 
restricted mouth opening. It allows reduced anaesthetic requirement for 
airway tolerance and smoother emergence. 
 
INFLATION LINE: 
 It is attached to the mask and terminates in pilot balloon with one way 
check valve for mask inflation and deflation. 
 Low volume inflation enables conformity of mask to the anatomy.  
 The seal is formed by matching the shape and not by the mucosal 
pressure. 
 
AIRWAY TUBE: 
 The LMA evolution curve is elliptical in cross section and anatomically 
shaped facilitating easy insertion. 
 It permits easy insertion without digital or introducer guidance. 
 It provides enough flexibility to permit the device to remain in place if 
the patients head is moved in any direction.  
 The two lateral grooves prevent the airway tube kinking when flexed. 
 
 
DRAIN TUBE: 
 Emerges as a separate port proximally and continues distally along the 
anterior surface of the cuff bowl, passing through the distal end of the 
cuff to communicate distally with the upper oesophageal sphincter.  
 Prevents gastric insufflation during ventilation, hence reduces likelihood 
of regurgitation 
 Enables active and passive decompression of stomach. 
 It is also used to monitor the correct positioning of LMA Supreme 
following insertion and for any displacement of mask during its use.  
 
INTEGRAL BITE BLOCK: 
 Reduces the potential for tube damage and obstruction by patient biting 
 
FIXATION TAB: 
 It is a specially designed rigid tab fixed above the bite block area that 
permits novel fixation method using adhesive tapes 
 Facilitates optimal positioning in oropharynx, hypopharynx and upper 
oesophagus 
 Whenever there is a leak around the cuff or the drain tube this tab can be 
manipulated easily to reposition the device to optimal position. 
 It indicates correct sizing of LMA 
 Positioned flush against the patients upper lip indicates the need for 
larger sized LMA 
 Positioned > 2.5 cm from upper lip indicates the need for smaller 
sized device. 
 SIZES AVAILABLE 
 
MASK SIZE 
 
PATIENT SIZE 
MAXIMUM 
CUFF 
INFLATION 
VOLUME 
 
MAXIMUM 
SIZE OG TUBE 
SIZE 1 < 5 kg 5 ml 6 FR 
SIZE 2 10 – 20 kg 12 ml 10 FR 
SIZE 3 30 – 50 kg 30 ml 14 FR 
SIZE 4 50 – 70 kg 45 ml 14 FR 
SIZE 5 70 – 100 kg 45 ml 14 FR 
  
The appropriate size of LMA Supreme is selected by using fixation tab position 
as already described. 
 
 
PERFORMANCE TESTS
23
: 
The following inspections and tests must be conducted before use of the device. 
The performance tests should be conducted in an area and in a manner 
consistent with accepted medical practice that minimise contamination of the 
LMA Supreme before insertion.  
 
1) VISUAL INSPECTION: 
 Examine the surface of the LMA Supreme and drain tube for damage 
including cuts, tears, scratches or kinks. 
 Examine the interior of the airway tube and drain tube to ensure they are 
free from blockages, loose particles and kinking of the drain tube within 
the airway tube. Any particles present in the tubes should be removed. Do 
not use the airway if the blockage or particle cannot be removed. 
 
2) INFLATION AND DEFLATION: 
 Deflate the cuff completely. Once deflated, check the cuff for 
spontaneous inflation. Do not use the airway if the cuff spontaneously 
inflates. 
 
DEVICE DEFLATION: 
 Firmly connect a syringe of at least 50 ml to the inflation port 
 Move the connected syringe away from the device until the inflation line 
is slightly stretched. 
 Compress the distal end of the device in between the index finger and 
thumb while withdrawing air until a vacuum is created. 
 While deflating hold the device so that the distal end is slightly curled 
anteriorly. 
 Deflate the device until the tension in the syringe indicates a vacuum in 
the mask. 
 Keep the syringe under tension and rapidly disconnect it from the 
inflation port. 
 
 
 
 DEVICE INSERTION: 
 Lubricate the posterior surface of the mask and airway tube just prior to 
insertion. 
 Stand behind the patients head. 
 Place the head in the neutral or slight “sniffing” position 
 Hold the device at the bite block 
 Press the tip of the mask against the hard palate 
 Press the cuff further into the mouth, maintaining pressure against the 
palate. 
 Swing the device inward with a circular motion, pressing against the 
contours of the hard palate and the soft palate.  
 Advance the device into the hypopharynx until resistance is felt. 
 
DEVICE FIXATION: 
 Use a piece of adhesive tape 30 – 40 cm long, holding it horizontally by 
both hands. 
 Press the adhesive tape transversely across the fixation tab with the 
middle of the tape pressing vertically downward over the tab. 
 Do not rotate the tape around the proximal end of the device  
 
DEVICE INFLATION: 
 Inflate the cuff with air until relevant intra – cuff pressure is reached. The 
recommended intra-cuff pressure should never exceed 60 cm H2O. 
 If there is no manometer by hand, inflate with just enough air to achieve a 
seal sufficient to permit ventilation without leaks. 
 
DIAGNOSTIC TESTS TO CONFIRM PLACEMENT 
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                               YES                              NO 
 
 
                            
                               YES 
 
 
 
 
Insert LMA Supreme using standard 
insertion technique, tape the mask in place 
then inflate the mask 
Check bite block position – lie between the 
teeth 
Distal end of the drain tube is not 
correctly placed – poor second seal. 
Re insert the LMA Supreme using 
standard insertion technique. 
Perform Supra sternal notch test. 
Is there slight lubricant movement when SSN 
is tapped with the index finger? 
LMA Supreme insertion into glottis – will 
observe bubble being blown out or 
lubricant sucked down drain tube. 
Re insert the LMA Supreme using 
standard insertion technique. 
Now ventilate. Does the lubricant remain 
stationary? 
Insert an orogastric tube to confirm drain 
tube patency 
Insufficient depth of insertion – there is 
bubble formation at the end of the drain 
tube. 
Advance LMA Supreme further until 
resistance is felt. 
              Check seal pressure 
 OROGASTRIC TUBE INSERTION: 
The primary function of drain tube is to provide a separate conduit from and to 
the alimentary tract. The gastric tube is well lubricated and then passed down 
the drain tube of LMA Supreme without any haste or force. A slight resistance 
is normal and is felt as the tip passes against the upper oesophageal sphincter.  
 
There may be difficulty in passing the gastric tube due to the following reasons 
1. Selection of too large gastric tube 
2. Inadequate lubrication 
3. Use of cooled gastric tube 
4. Cuff over inflation 
5. Malposition of LMA Supreme 
 
The advantages of inserting gastric tube are 
1. It allows active and passive decompression of stomach 
2. It helps to confirm correct placement of LMA Supreme 
3. It acts as a monitor for any displacement during the use.  
  
 
 
 
 
 
 REVIEW OF LITERATURE 
 
The literature was searched and reviewed to seek the advantages and 
disadvantages of LMA-Supreme use over ETT for general anaesthesia in 
elective laparoscopic gynaecological surgeries. 
 
1)Abdi W, Amathieu R, Adhoum A, Poncelet C, Slavov V, Kamoun W, 
Combes X, Dhonneur G
1
 compared the efficiency and post operative upper 
airway morbidity of LMA- Supreme and endotracheal tube in elective 
laparoscopic gynaecological surgeries. 
 
One hundred and thirty eight elective pelvic laparoscopic ASA I-II female 
patients were enrolled in the study. They were randomly assigned into two 
groups – LMA Supreme group(SUP) and endotracheal tube group(ETT). 
Anaesthesia management was identical in both the groups and included 
induction with propofol/sufentanyl/atracurium, maintenance with sevoflurane 
and sufentanyl, muscle relaxation with atracurium and IPPV. 
 
The airway management duration in LMA Supreme group was 2.2 mins and in 
ETT group was 3.8 mins. Post operative pharyngolaryngeal discomfort 
incidence was significantly less after SUP anaesthesia than ETT anaesthesia. 
Hoarseness of voice was less frequent in LMA-S group compared to ETT group 
both in PACU (16% vs 47%, respectively P<0.05) and before discharge (9% vs 
37%, respectively P<0.05). Sore throat was less frequent in LMA-S group 
compared to ETT group both in PACU (19% vs 32%, respectively P<0.05) and 
before discharge (5% vs 15%, respectively P<0.05). 
 
The study concluded LMA-Supreme as an effective pharyngolaryngeal 
morbidity sparing strategy and an equally effective airway device to ETT for 
gynaecological laparoscopic surgeries. (Acta Anaesthesiologica Scandinavica 
2010; 54: 141–146) 
 
2) Vila, P.; Sirvent, A.; Gomez, N.; Mazo, V.; Preciado, M. J.
2
 compared the 
insertion conditions, airway seal and efficacy of ventilation of LMA- Supreme 
and Endotracheal tube in laparoscopic gynaecological surgeries in trendlenburg 
position. 
 
Anaesthesia was induced with propofol/fentanyl and maintained with 
desflurane/air in both SLMA group and ETT group. No. of insertion attempts 
and time to establish an effective airway were recorded. Ease of placing gastric 
tube was measured. EtCO2 was recorded at rest, after pneumoperitoneum and 
after trendlenburg positioning 
. 
Number of insertion attempts was similar in both the groups (1.1 vs 1; SLMA 
and ETT, respectively). The time taken to establish an effective airway were 
similar in both the groups (14s vs 17s; SLMA and ETT, respectively). EtCO2 
was similar in both the groups at all moments.  
 
The study concluded LMA-Supreme as a practicable approach for 
gynaecological laparoscopic surgeries in trendlenburg position.  (European 
Journal of Anaesthesiology: 12 June 2010 - Volume 27 - Issue 47 - p 250–251, 
Airway Management) 
 
3) Pelikan, K.; Dadak, L.
9
 assessed the efficacy of LMA- Supreme(SLMA) as 
airway management device in patients undergoing prolonged surgeries. Ease of 
insertion of SLMA, number of attempts for successful insertion, ease of 
insertion of gastric tube, postoperative sore throat were studied. 
 
SLMA was successfully used in all cases. The first time insertion success rate 
was 93%. Gastric tube was inserted with ease, with first attempt success rate of 
100%. Gastric content was 0 ml at the end of anaesthesia in 46%. Incidence of 
sore throat was 5%. No patient reported of hoarseness of voice. 
The study concluded LMA-Supreme as a suitable and safe alternative to 
tracheal intubation in prolonged anaesthesia. (European Journal of 
Anaesthesiology: 12 June 2010 - Volume 27 Issue 47 - p 251, Airway 
Management) 
 
4)Belena JM, Gracia JL, Ayala JL, Nunez M, Lorenzo JA, De los reyes A, 
Perez JL, Yuste J
16
 evaluated the efficacy of LMA-Supreme in patients 
undergoing laparoscopic cholecystectomy with general anesthesia. Ease of 
insertion of the device and the drain tube, gastric distension, frequency of post 
operative sore throat, and other adverse events were recorded. 
 All patients were premedicated with midazolam and preoxygenated. Induced 
with propofol/remifentanyl. SLMA was inserted and the number of insertion 
attempts, the time taken for an effective airway was recorded. A 14 Fr drain 
tube was inserted via the drain tube, its ease of insertion and number of attempts 
were recorded. Gastric distension was noted by the surgeon and scored on an 
ordinal scale from 0 to 10. Hemodynamic parameters were recorded every 3 
minutes. Post operative sore throat was assessed. 
 
The success rate of SLMA insertion was 100% with 91 patients on first attempt 
and 9 patients on second attempt. The mean time for SLMA insertion was 
12±4.6 seconds. The success rate of gastric tube insertion was 100% (easy in 97 
pts, difficult in 3). Twelve patients (12%) complained of sore throat post 
operatively. 
 
The study concluded LMA-Supreme as easy to insert and an effective 
ventilatory device for laparoscopic cholecystectomy. (Journal of Clinical 
Anesthesia. 2011 Sep;23(6):456-60.) 
 
5)Teoh WH, Lee KM, Suhitharan T, Yahaya Z, Teo MM, Sia AT
11
 
compared the efficacy of LMA-Supreme and I-Gel in patients posted for 
laparoscopic gynaecological surgeries. The ease of insertion, success rate of 
insertion at first attempt, ease of gastric tube insertion, blood staining of devices 
and post operative sore throat were studied. 
 
Ease of insertion was similar for both the devices, 88% graded easy in both the 
groups (p=1.000). The success rate of insertion at first attempt was comparable 
in both the groups (94% in LMA-S vs 96% in I-Gel). The time taken for 
insertion was comparable in both the groups (14.3 s in LMA-S vs 15.4 s in I-
Gel; p=0.4). 
 
Gastric tube insertion was easier and achieved more quickly with the LMA-
Supreme group than I-Gel group (9.0 s vs 15.1 s, respectively; p<0.001). Ease 
of gastric tube insertion was easy in 100% of LMA-S group vs 78% of I-Gel 
group. (p<0.001) 
 
The study concluded that both the devices as equally effective in gynaecological 
laparoscopic surgeries. (Anaesthesia. 2010 Oct 19.) 
 
6) Tan BH, Chen EG, Liu EH
17 
evaluated the efficacy of LMA-Supreme in 
100 patients. The success rate of insertion at first attempt was 96% and at 
second attempt was 100%. Time to achieve effective ventilation was 15.0 sec 
(12 – 18 s). The success rate of gastric tube insertion was 100%. The incidence 
of sore throat and blood staining were found to be 7%. 
 
The study concluded LMA-Supreme was easy to insert with high rate of optimal 
positioning at first attempt with less incidence of airway trauma. (Anaesthesia 
and Intensive Care. 2010 May; 38(3):550-4) 
 
 
 7)Seet E, Rajeev S, Firoz T, Yousaf F, Wong J, Wong DT, Chung F
18
 
compared the safety and efficacy of LMA-supreme and LMA-Proseal in 
elective ambulatory surgeries.  
 
The success rate of first attempt insertion was higher with LMA-Supreme group 
than for Proseal group. (98% vs 88%; p = 0.04). None of the insertion graded 
difficult in LMA-Supreme group against 3 difficult insertion in proseal group. 
The incidence of blood staining in Supreme group was less than the proseal 
group (10% vs 16.3% respectively). The incidence of post operative sore throat 
was less in Supreme group compared to Proseal group (11.8% vs 16.3%, 
respectively). 
 
The study concluded LMA-Supreme as safe, efficacious and easy-to-use 
disposable airway device in elective ambulatory surgeries. (Europeon Journal 
of Anaesthesiology. 2010 Jul;27(7):602-7) 
 
8. Maltby J Roger, Beriault Michael T, Watson Neil C, Liepert David J, 
Fick Gordon H
4
 compared the laryngeal mask airways (LMA), LMA-
Classic(TM) (LMA-C) and LMA-ProSeal(TM) (PLMA) with the endotracheal 
tube (ETT) with respect to pulmonary ventilation and gastric distension during 
gynecologic laparoscopy. 
 
There were no statistically significant differences between LMA-C/PLMA and 
ETT groups for SpO2, P(ET)CO(2) or airway pressure before or during 
peritoneal insufflation in short (< or = 15 min) or long (> 15 min) periods of 
peritoneal inflation. Differences between groups with respect to stomach size 
changes during surgery were not statistically significant. 
 
The study concluded that a correctly placed LMA-C or PLMA provided equally 
effective ventilation as ETT without clinically important gastric distension. (Can 
J Anaesth. 2003 Jan; 50(1):71-7) 
 
9) Lee AK, Tey JB, Lim Y, Sia A
20
 compared the LMA-Supreme with Proseal 
LMA in seventy patients undergoing general anaesthesia with paralysis for 
gynaecological surgeries. 
 
The ease of insertion were comparable between SLMA and PLMA with success 
rate of placement at first attempt being 94.3% vs 91.4%, respectively. The time 
for effective ventilation did not differ significantly (25±22 secs in SLMA vs 
24±9 secs in PLMA; p=0.739). 
 
Gastric tube insertion was completed in significantly less time with SLMA (5±1 
s vs 7±3 s; p<0.001). The incidence of sore throat was similar, 9% in both 
groups. No patients in SLMA group complained of hoarseness of voice. 
(Anaesthesia and Intensive Care. 2009 Sep;37(5):815-9.) 
 
10) Chew E, Hashim N, Wang C
22
 compared the performance of the LMA 
Supreme (SLMA) with the I-Gel during anaesthesia in spontaneously breathing 
adult patients. The overall insertion success rate, ease of insertion, adequacy of 
ventilation and incidence of complications were studied. 
 
The first attempt and overall insertion success rates were similar between the 
two groups (SLMA 97.8 and 97.8%; I-Gel 93.3 and 100%, P=0.132). The 
SLMA was rated easier to insert than the I-Gel (P=0.011), but the time taken for 
insertion (P=0.433) was similar. The incidence of complications was low in 
both groups (9.5% in SLMA vs 4.4% in I-Gel). 
 
The study concluded that SLMA was easier to insert compared I-Gel and 
provides better airway seal. (Anaesthesia and Intensive Care 2010; 38: 1018-
1022) 
 
11)Ali A, Canturk S, Turkmen A, Turgut N, Altan A
8
 compared the LMA 
Classic with the LMA Supreme in assessing the success rate and time for 
insertion, number of attempts. In the LMA Classic group and the LMA Supreme 
group, the LMA was successfully inserted in the first attempt in 27 (77%) and 
31 (88.5%) patients, respectively. The duration of insertion in the LMA 
Supreme group was shorter. (8.0±1.7sec vs 11.2±2.5sec, respectively;p<0.001) 
The incidence of sore throat was 2.8% with LMA-Supreme group vs 5.7% in 
LMA-Classic group.  
 
The study concluded  LMA Supreme as superior to LMA Classic as regards its 
ease of insertion and effective ventilation.(Europeon Journal of 
Anaesthesiology. 2009 Dec;26(12):1010-4) 
 12)Eschertzhuber S, Brimacombe J, Hohlrieder M, Keller C
24
 evaluated the 
ease of insertion of airway device, their success rate  and ease of gastric tube 
placement  between the LMA ProSeal and the LMA Supreme in paralysed 
anesthetised patients. First attempt and overall insertion success were similar 
(LMA ProSeal, 92% and 100%; LMA Supreme 95% and 100%). The first 
attempt and overall insertion success for the gastric tube were similar (LMA 
ProSeal 91% and 100%; LMA Supreme 92% and 100%).(Anaesthesia. 2009 
Jan;64(1):79-83.) 
 
14)Tham HM, Tan SM, Woon KL, Zhao YD
26
 tested the hypothesis that the 
SLMA is equally as effective as the PLMA as a supraglottic ventilatory device 
in anesthetized paralyzed adult patients. The success rate of insertion is 100% 
with 97% inserted in first attempt and 3% in second attempt. The time taken for 
insertion was 20 seconds comparable to that of PLMA, 20 secs(P=0.882) 
The success rate of gastric tube insertion was 100%, with mean time for 
insertion being 10.3 seconds in SLMA against 11 seconds in PLMA.  
 
 The study concluded that the clinical performance of SLMA as a ventilator 
device was comparable with that of PLMA. Canadian Journal of 
Anaesthesiology. 2010 Jul;57(7):672-8 
 
15)Lopez AM, Valero R, Brimacombe J
27
 investigated whether insertion of an 
LMA Supreme and its use for maintenance of anaesthesia is feasible in the 
prone position. Ease of insertion, ease of ventilation, efficacy of seal, ease of 
gastric tube insertion, blood staining, postoperative sore throat, and other 
complications were recorded. 
 
Insertion was successful at the first and second attempt in 37 (92.5%) and 3 
(7.5%) patients, respectively. The mean (SD) insertion time was 21 (15) s. 
Gastric tube placement was successful in all patients. The frequency of blood 
staining and sore throat was 7.5% each. 
 
It was concluded that use of the LMA Supreme in the prone position by 
experienced users is feasible. Anaesthesia. 2010 Feb;65(2):154-7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 AIM OF THE STUDY 
 
    To evaluate the advantages and disadvantages of LMA- Supreme (LMA-S) 
over Endotracheal tube (ETT) for general anaesthesia in women coming for 
laparoscopic gynaecological surgeries in terms of the following parameters. 
 
1. Ease of insertion of airway device 
2. No. of attempts for insertion of airway device 
3. Time taken for insertion of airway device 
4. Ease of insertion of gastric tube 
5. No. of attempts for insertion of gastric tube 
6. Gastric distension 
7. Haemodynamic responses 
8. Capnography 
9. Blood staining of devices 
10. Incidence of complications 
 
 
 
 
 
 
 
 MATERIALS AND METHODS 
 
It was a prospective, randomised, single - blinded, case - controlled study 
conducted in the Department of Anaesthesiology, Kasturba Gandhi Hospital, 
Chennai. 60 adult patients satisfying the inclusion criteria were enrolled in the 
study. 
 
INCLUSION CRITERIA: 
 Age : 18 years and above 
 Weight : BMI < 30 kg/m
2
 
 ASA : I & II 
 Surgery : Elective 
 Mallampatti scores : I & II 
 Who have given valid informed consent 
 
EXCLUSION CRITERIA: 
 Not satisfying inclusion criteria 
 Patients posted for emergency surgery 
 Patients with difficult airway 
 Lack of written informed consent 
 Pregnant female 
 
 
 MATERIALS: 
 LMA Supreme size 3 & 4 
 Endotracheal tubes- 7 & 7.5 mm CETT 
 Macintosh laryngoscope with blade size 3 
 20 ml syringe 
 Lubricant jelly, 14 Fr orogastric tube 
 Drugs: glycopyrolate, fentanyl, midazolam, ondansetron, propofol, 
atracurium, sevoflurane, neostigmine 
 Monitors: ECG, Pulse oximetry, Capnography, NIBP 
 Weighing machine calibrated to 1 kg 
 
STUDY OUTCOME: 
 
1. Ease of Insertion of Airway Device: 
The ease with which the patient was intubated was judged subjectively on 
nominal scale as “easy (E)” or “difficult (D)”. 
 
2. No of insertion attempts: 
The no. of attempts required for successful intubation was recorded. A 
“failed attempt” was defined as a removal of the device from the patient 
mouth or maximum of 3 attempts. 
3. Time taken for insertion: 
It is defined as the time elapsed between picking up of airway device in 
the hand until the presence of square wave capnography trace. 
 4. Ease of insertion of gastric tube: 
The ease of insertion was graded subjectively as Easy or Difficult. It is 
considered difficult when there is a resistance to insertion, when more 
than one attempt is required, manoeuvres like lifting trachea or deflating 
cuff is required. 
 
5. No. of attempts for gastric tube insertion: 
The no. of attempts required for successful gastric tube placement was 
recorded. The successful p lacement was defined as detection of injected 
air by auscultation of epigastrium and aspiration of gastric contents. 
 
6. Gastric distension: 
It was measured by the operating gynaecologist before peritoneal 
deflation. It was graded on an ordinal scale from 0 – 10. (0 = empty 
stomach and 10 = distension of the stomach that interfered with surgical 
field) 
 
7. Haemodynamic reponses:  
The patients pulse rate and blood pressure were recorded before 
intubation, immediately after intubation and one minute, 3 minutes and 5 
minutes post intubation. 
 
 
 
 8. End tidal carbondioxide: 
The EtCO2 was measured after intubation, after peritoneal inflation and 
after peritoneal deflation. 
 
9. Blood staining of the device: 
At the end of surgery the airway device was removed after adequate 
recovery. The presence or absence of blood on the device was noted. 
 
10. Incidence of complications: 
The patients were asked whether they experienced sore throat or 
hoarseness of voice after the removal of airway device. 
Sore throat was defined as a constant pain or discomfort in the throat 
independent of swallowing. 
Hoarseness of voice was defined as either change in the voice tone or a 
painful phonation. 
 
 
CONDUCTION OF THE STUDY: 
After obtaining institutional ethical committee clearance, all patients scheduled 
for elective laparoscopic gynaecological surgery under general anaesthesia were 
screened for any comorbid illness and difficult airway. Age, height and weight 
were assessed. 60 Patients satisfying the inclusion criteria were enrolled in the 
study. A written informed consent was obtained and the patients were allocated 
randomly into two groups, LMA-S and ETT, with 30 each by using closed 
envelop method. The size of the airway was chosen in accordance to 
manufacturers recommendations. 
 
All patients were premedicated with Inj. Midazolam 1 mg iv, Inj. Ondansetron 4 
mg iv, Inj.glycopyrolate 0.2 mg iv in the pre anaesthesia room. The patients 
were shifted inside the operating room and placed in supine position. ECG 
monitor, pulse oximetry and non invasive blood pressure monitor were 
connected. Baseline BP, HR and SpO2 were recorded. 
All patients were preoxygenated with 100% oxygen at a flow rate of 6L/min for 
3 minutes by using tight fitting mask. Patient was induced with Inj. Fentanyl 
2µ/kg and Inj. Propofol 2 mg/kg. Inj. Atracurium 0.5mg/kg was administered 
for neuromuscular blockade after confirmation of successful manual bag-mask 
ventilation. Patient was ventilated for 3 mins. Pre intubation BP, HR and SpO2 
were recorded. 
 
In ETT group conventional laryngoscopy was performed with macintosh 3 
blade with the head in sniffing position . The trachea was intubated using a 
single use 7.0/7.5 mm internal diameter high-volume, low- pressure tracheal 
tube. The cuff was inflated until no leak was audible during manual ventilation. 
 
In LMA-S group, the appropriate sized LMA-S was inserted in sniffing position 
as per manufacturers recommended technique and is taped in position. The cuff 
is inflated with just enough air to achieve a seal sufficient to permit ventilation 
without leaks. The appearance of first square end tidal carbon dioxide trace was 
noted as a indicator of effective ventilation. Otherwise the device was 
completely removed for another insertion attempt, with a maximum of 3 
attempts allowed. The ease of insertion, no of attempts taken for successful 
placement and the time taken for insertion were recorded in both the groups. 
In LMA-S group, a water soluble lubricant was placed in the proximal 1 cm of 
the drain tube, and the suprasternal notch test was performed to confirm the 
placement. 
 
The gastric tubes were lubricated well. In LMA-S group the appropriate sized 
gastric tube was inserted through the drain tube port. In ETT group the gastric 
tube was inserted nasally. Ease of insertion and no of attempts for successful 
insertion was noted. Gastric decompression was performed immediately after 
insertion. 
Anaesthesia was maintained with sevoflurane 2% and N2O: O2 at 2:1 ratio. 
Muscle relaxation was maintained with Inj.atracurium 0.1mg/kg. The BP, HR 
and SpO2 were recorded immediately after intubation and after one minute, 3 
minutes and 5 minutes. Initial ventilator tidal volumes were set at 8ml/kg. 
Volume controlled positive pressure ventilation was used to achieve O 2 
saturation of   >95% and end tidal CO2 of 30- 45 mm Hg through tidal volume 
8-10ml/kg and respiratory rate of 10-16/min. 
 
All patients were positioned head down. The trendelenberg tilt was provided as 
per the gynaecologists request. Pneumo peritoneum was created with CO2 gas 
and intra abdominal pressure was maintained <15 mm Hg. EtCO2 was recorded 
after peritoneal inflation. The gynaecologist was requested to grade the gastric 
distension before deflation. EtCO2 was recorded after peritoneal deflation.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 At the end of surgery, the effects of neuromuscular blockade was reversed with 
Inj. Neostigmine 0.04mg/kg and Inj. Glycopyrolate 0.01 mg/kg iv. After 
thorough oral suction the cuff was deflated and the airway device was removed 
upon return of spontaneous breathing and eye opening of the patient. The 
airway device was inspected for the presence of any visible blood. 
 
The following complications were recorded –cough, stridor, laryngospasm and 
hypoxia. Patients were evaluated for the presence of sore throat and hoarseness 
of voice before leaving the operating room and 2 hours post operatively in the 
recovery room. 
 
All recorded datas were analysed with SPSS software for Windows Version 
15.0. The quantitative datas were analysed by students t-test and the qualitative 
data by chi-squared test. Power analysis was calculated using Minitab for 
windows and the power was well above the accepted level of 80%. 
 
 
 
 
 
 
 
 
 OBSERVATION AND RESULTS  
 
This prospective, randomized, comparative, single blinded case control study    
compares LMA-Supreme insertion with Endotracheal tube in 60 adult females 
undergoing elective laparoscopic gynaecological surgery.  
 
Results are expressed as mean and standard deviation. All statistical analyses 
were carried out using SPSS for Windows version 15.0. The t-test was used for 
comparison of quantitative variants. Qualitative variants were compared using 
the chi-squared test. A P value of less than 0.05 was considered statistically 
significant. 
 
Table: 1 Demographic profile: Age 
 
Group N Mean SD P value 
LMA-S 30 28.43 6.71 0.879 
 ETT 30 28.20 4.99 
 
The mean age of group LMA-S is 28.43 and group ETT is 28.2. The data is 
statistically not significant (p>0.05) and this both groups are comparable in 
terms of age. 
 
 
 
 
 
 Table: 2 Demographic profile: BMI 
 
Group NO Mean SD P value 
LMA-S 30 23.19 1.67 0.375 
Not 
significant 
ETT 30 22.63 2.96 
 
The mean BMI of group LMA-S is 23.19 and group ETT is 22.63. 
The data is statistically not significant (p>0.05) and this both groups are 
comparable in terms of BMI. 
 
Table: 3 Demographic profile: ASA PS Status 
 
GROUP ASA I ASA II P value 
NO % NO % 0.739 
Not 
significant 
LMA-S 25 83.3 5 16.7 
ETT 24 80.0 6 20.0 
 
In LMA-S group 25 patients were ASA I and 5 were ASA II patients. In ETT 
group 24 patients were in ASA I and 6 were ASA II patients.  
The data is statistically not significant (p>0.05) and this both groups are 
comparable in terms of ASA PS Status. 
 
 
 
 
 
 
 
 Table: 4 Demographic profile: MPC 
 
GROUP MPC I MPC II P value 
NO % NO % 1.000 
Not 
significant 
LMA-S 21 70.0 9 30.0 
ETT 21 70.0 9 30.0 
 
In LMA-S group 21 patients were MPC I and 9 were MPC II patients. In ETT 
group 21 patients were in MPC I and 9 were MPC II patients.  
The data is statistically not significant (p>0.05) and this both groups are 
comparable in terms of MPC. 
 
Table: 5 Ease of insertion of airway device 
 
Group NO Easy Difficult P value 
  NO % NO % 0.314 
 
Not 
significant 
LMA-S 30 29 96.7 1 3.3 
ETT 30 30 100 0 0 
 
By using LMA-S, 29 cases were inserted easily and 1 case was inserted with 
difficulty. By using ETT all 30 cases were intubated easily. 
Qualitative data values are compared by chi-square test. Statistical analysis 
reveals P value of 0.314 which is not statistically significant at 5% interval.  
 
 
 
 
 
 Table: 6 No of attempts 
 
Group No Success in P value 
  1
st
 
attempt 
% 2
nd
 
attempt 
% 0.313 
Not 
significant LMA-S 30 29 96.7% 1 3.3% 
ETT 30 30 100% 0 0 
 
LMA-S insertion was successful in 29/30 in first attempt while 1 patient 
required second attempt. ETT insertion was successful in all 30 patients in the 
first attempt.  
Statistical analysis reveals P value of 0.313. the two groups are statistically 
insignificant in no of attempts required for successful insertion.  
 
Table: 7 Time taken for insertion 
 
Group No Mean SD P value 
LMA-S 30 15.20 2.70 <0.001 
Significant ETT 30 24.77 2.54 
 
The mean time taken for insertion in LMA-S group is 15.2 seconds and the 
mean time taken for insertion in ETT group is 24.77 seconds.  
Student’s t test reveals P value of <0.001 which is statistically significant.  
 
 
 
 
 
 
 Table: 8 Ease of insertion of Gastric tube 
 
Group NO Easy Difficult P value 
  NO % NO % 0.005 
significant LMA-S 30 30 100 0 0 
ETT 30 23 76.7 7 23.3 
 
In LMA-S group, gastric tube was inserted easily in all 30 cases. In ETT group 
gastric tube was inserted easily in 23 patients and with difficulty in 7 patients. 
Qualitative data values are compared by chi-square test. Statistical analysis 
reveals P value of 0.005 which is statistically significant at 5% interval.  
 
Table: 9 No of attempts for gastric tube insertion 
 
Group No Success in P value 
  1
st
 
attempt 
% 2
nd
 attempt %  
0.076 
Not 
significant 
LMA-S 30 30 100% 0 0 
ETT 30 27 90% 3 10% 
 
In LMA-S group, gastric tube insertion was successful in all 30 patients in first  
attempt. In ETT group, gastric tube insertion was successful in 27 patients in the 
first attempt and in 3 patients in second attempt.  
Statistical analysis reveals P value of 0.076. The two groups are statistically 
insignificant in no of attempts for gastric tube insertion. 
 
 
 
 Table: 10 Gastric distension 
 
 
SCALE 
LMA-S ETT P value 
NO % NO % 
0 19 63.3 21 70.0 0.327 
Not significant 1 8 26.7 4 13.3 
2 3 10.0 2 6.7 
3 0 0 2 6.7 
5 0 0 1 3.3 
 
Student’s t-test reveals P value of 0.327 which is not significant. This indicates 
that LMA-S provides good airway seal and adequate pulmonary ventilation 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table: 11 SpO2 
 
 Group No Mean SD P value 
Baseline LMA-S 30 99.43 0.85 0.229 
Not 
significant 
ETT 30 99.67 0.60 
Pre 
insertion 
LMA-S 30 99.70 0.65 0.479 
Not 
significant 
ETT 30 99.80 0.40 
Post 
insertion at 
0 min 
LMA-S 30 99.57 0.72 0.849 
Not 
significant 
ETT 30 99.60 0.62 
Post 
insertion at 
1 min 
LMA-S 30 99.77 0.43 0.325 
Not 
significant 
ETT 30 99.87 0.34 
Post 
insertion at 
3 min 
LMA-S 30 99.87 0.34 0.325 
Not 
significant 
ETT 30 99.77 0.43 
Post 
insertion at 
5 min 
LMA-S 30 99.97 0.18 0.168 
Not 
significant 
ETT 30 99.77 0.42 
 
SpO2 was measured preoperatively, before intubation, immediately after 
intubation, at 1 minute, 3 minutes and 5 minutes post intubation. 
Statistical analysis by students t test reveals P value of 0.229, 0.479, 0.849, 
0.325, 0.325 and 0.168 respectively which are not significant. Hence there is no 
significant oxygenation difference between two techniques. 
 
 
 
 Table: 12 Haemodynamic Responses 
 
Table: 12a Heart Rate 
 
 Group No Mean SD P value 
Baseline LMA-S 30 97.80 13.35 0.196 
Not 
significant 
ETT 30 93.13 14.28 
Pre 
insertion 
LMA-S 30 90.13 14.06 0.468 
Not 
significant 
ETT 30 92.83 14.54 
Post 
insertion at 
0 min 
LMA-S 30 94.43 15.38 0.014 
significant 
 
ETT 30 104.2 14.55 
Post 
insertion at 
1 min 
LMA-S 30 91.53 12.98 0.008 
significant ETT 30 101.17 14.15 
Post 
insertion at 
3 min 
LMA-S 30 88.7 12.04 0.015 
significant ETT 30 97.03 13.76 
Post 
insertion at 
5 min 
LMA-S 30 87.47 11.58 0.018 
significant ETT 30 95.37 13.51 
 
 
 
 
 
 
 
 
 
 Table: 12b Systolic Blood Pressure 
 
 Group No Mean SD P value 
Baseline LMA-S 30 122.33 12.29 0.482 
Not 
significant 
ETT 30 120.13 11.78 
Pre 
insertion 
LMA-S 30 97.60 10.79 0.299 
Not 
significant 
ETT 30 100.63 11.61 
Post 
insertion at 
0 min 
LMA-S 30 107.13 12.36 0.035 
significant ETT 30 114.03 12.38 
Post 
insertion at 
1 min 
LMA-S 30 107.77 9.65 0.028 
significant ETT 30 113.93 11.48 
Post 
insertion at 
3 min 
LMA-S 30 108.73 8.80 0.002 
significant ETT 30 116.83 10.44 
Post 
insertion at 
5 min 
LMA-S 30 107.70 7.53 0.001 
significant ETT 30 115.60 9.54 
 
 
 
 
 
 
 
 
 
 
 
 Table: 12cDiastolic Blood Pressure 
 
 Group No Mean SD P value 
Baseline LMA-S 30 81.40 8.66 0.071 
Not 
significant 
ETT 30 77.50 7.73 
Pre 
insertion 
LMA-S 30 63.63 9.24 0.230 
Not 
significant 
ETT 30 66.13 6.46 
Post 
insertion at 
0 min 
LMA-S 30 65.90 9.04 <0.001 
significant ETT 30 75.00 6.82 
Post 
insertion at 
1 min 
LMA-S 30 67.80 8.07 0.001 
significant ETT 30 74.40 6.17 
Post 
insertion at 
3 min 
LMA-S 30 68.13 7.68 <0.001 
significant ETT 30 76.00 5.73 
Post 
insertion at 
5 min 
LMA-S 30 67.13 4.99 <0.001 
significant ETT 30 75.33 5.37 
 
 
 
 
 
 
 
 
 
 
 
 Table: 12d Mean Arterial Pressure 
 
 Group No Mean SD P value 
Baseline LMA-S 30 94.98 9.12 0.155 
Not 
significant 
ETT 30 91.40 8.63 
Pre 
insertion 
LMA-S 30 74.90 9.04 0.192 
Not 
significant 
ETT 30 77.43 7.80 
Post 
insertion at 
0 min 
LMA-S 30 79.76 8.52 <0.001 
significant ETT 30 87.70 7.88 
Post 
insertion at 
1 min 
LMA-S 30 80.08 7.94 0.002 
significant ETT 30 87.20 7.04 
Post 
insertion at 
3 min 
LMA-S 30 81.43 7.26 <0.001 
significant ETT 30 89.26 6.33 
Post 
insertion at 
5 min 
LMA-S 30 80.33 4.98 <0.001 
significant ETT 30 88.43 5.86 
 
Heart rate, systolic blood pressure, diastolic blood pressure and mean arterial 
pressure were measured pre operatively, pre intubation, immediately after 
intubation and at 1mt, 3mt, 5mts after intubation. The actual values are 
documented in the tabular column. 
Statistical analysis by students t test reveals significant blood pressure and heart 
rate changes immediate post intubation, 1mt, 3mt, and 5mts after intubation.  
Hence there is a significant haemodynamic response with ETT when compared 
to LMA-S. 
 
Table: 13 EtCO2 
 
 Group No Mean SD P value 
Baseline LMA-S 30 36.97 0.85 0.835 
Not 
significant 
ETT 30 37.03 1.52 
Post 
inflation 
LMA-S 30 39.03 1.32 0.951 
Not 
significant 
ETT 30 39.07 2.67 
Post 
deflation 
LMA-S 30 37.07 1.55 0.058 
Not 
significant 
ETT 30 37.97 1.88 
 
EtCO2 was recorded after intubation, after peritoneal inflation with CO2 and 
after peritoneal deflation. The actual values are documented in the tabular 
column.  
Student’s t test reveals P value of 0.835, 0.951 and 0.058 respectively which are 
not significant. This indicates that LMA-S provides good pulmonary 
ventilation. 
 
Table: 14 Blood staining of devices 
Group No Blood staining P value 
Yes % No % 
LMA-S 30 2 6.7 28 93.3 0.150 
Not 
significant 
ETT 30 0 0 30 100 
 
Blood staining in the airway noted after extubation indicates airway trauma. It 
occurred in 2/30 cases with LMA-S and not seen with ETT. Chi square test 
reveals P value of 0.150 which is not significant.  
 
Table: 15 Incidence of complications 
 
 Group No Yes  No  P value 
Sore throat LMA-S 30 0 0 30 100 0.001 
Significant ETT 30 9 30 21 70 
Hoarseness of 
voice 
LMA-S 30 0 0 30 100 0.002 
Significant ETT 30 8 26.7 22 73.3 
Laryngospasm LMA-S 30 1 3.3 29 96.7 0.313 
Not 
significant 
ETT 30 0 0 30 100 
 
Sore throat occurred in no cases with LMA-S and 9/30 cases with ETT. 
Statistical analysis reveals a P value of 0.001 which is significant.  
Laryngospasm occurred in 1/30 of LMA-S group and is not seen with ETT 
group. Statistical analysis reveals P Value of 0.313 which is not significant. 
Hoarseness of voice did not occur with LMA-S group and seen in 8/30 patients 
in ETT group. Statistical analysis reveals P Value of 0.002 which is significant.  
 
 
 
 
 
 
 DISCUSSION 
 
LMA-Supreme, with its unique first and second seal provides effective positive 
pressure ventilation without the risk of gastric distension, regurgitation and 
aspiration of gastric contents. 
 
This study is designed to compare the clinical performance of LMA-Supreme 
with the conventional Endotracheal tube.  
 
Ease of insertion of airway device 
Insertion of LMA-Supreme was easy in vast majority of population. In our 
study LMA-Supreme is inserted with ease in 96.7% of patients. Both ETT and 
LMA-S are inserted with similar ease. 
 
This is in concurrence with the study conducted by Abdi et al
1
. They compared 
LMA-Supreme and ETT in gynaecological laparoscopic surgeries. In this study 
all the LMA-S insertion was graded easy (100%). Seet et al
18
 in 2010 
conducted a study to compare LMA-S and PLMA. Insertion was graded easy in 
100% of patients in LMA-S group. The small amount of difficulty in insertion 
found in our study can be explained by the inexperienced hands. 
 
 
 
Number of attempts to successful placement 
LMA-Supreme was successfully inserted and allowed optimal controlled 
ventilation in all patients. The first attempt success rate was 96.7% with overall 
insertion success of 100%.  
 
The studies conducted on LMA-Supreme by Tan et al
17
 and Belena et al
16
 
reported 100% and 91% first attempt success rate and as with our study, 
reported no failures of use. 
 
The overall success rate in many previous studies is 100%, and is achieved in 2 
attempts. 
 
Time taken for insertion of airway device: 
Securing an effective airway was rapid compared to ETT. The mean time to 
ventilation was 15.2 seconds, which is shorter than that required for ETT. Abdi 
et al in 2010 showed similar results by comparing LMA-Supreme and ETT.  
 
This is also strongly supported by the studies conducted by Tan et al
17
, Belena 
et al
16
 and Teoh et al
11
 with LMA-S. The mean insertion time was found to be 
15, 12 and 14.3 seconds, respectively. This smaller mean insertion time can 
particularly be beneficial when it is used as an airway rescue device. 
 
 
 
 
 Ease of insertion of gastric tube 
The smoother and more rigid gastric drain channel in the LMA-Supreme 
appears to facilitate the insertion of 14 Fr gastric tube with more ease compared 
to the conventional method employed with ETT. 
 
In our study, 100% of gastric tube insertions were graded as easy against 76.7% 
in ETT group. The study conducted by Abdi et al
1
 supports our observation. 
All the insertions made were successful. This indicates that in all cases the 
reinforced tip of LMA-S was never folded over. 
 
Belena et al
16
 and Teoh et al
11
 also showed that gastric insertion was easier and 
achieved more quickly with LMA-Supreme compared to other supraglottic 
airway devices. 
 
Number of attempts for gastric tube insertion 
In our study gastric tube was placed successfully in first attempt in all patients 
with the success rate of 100%. The first attempt success rate in ETT group was 
90%. This observation is strongly supported by Pellikan et al
9
 who evaluated 
the efficacy of LMA-S over ETT in laparoscopic surgery. 
 
 
 
 
 
 Gastric distension 
In our study there was no significant gastric distension with both the groups. 
LMA-Supreme thus provides an added advantage over older supraglottic 
devices by preventing aspiration. Kohama et al
25
 compared Supreme with 
SoftSeal laryngeal masks. The amount of air entering the stomach was 
significantly lower with the Supreme than the Soft Seal (14.6±11.8 ml vs 
180.2±123.0 ml, respectively; P<0.005). 
 
Pulmonary ventilation 
In our study there was no significant difference in SpO2 between two groups. 
EtCO2 did not differ significantly before inflation, after inflation and after 
deflation between both groups. This is supported by the study done by Vila et 
al
2
 who compared LMA-Supreme with ETT in laparoscopic gynaecological 
surgeries. Etco2 were similar in both the groups at all moments. Thus LMA-
Supreme provides good pulmonary ventilation and can act as an alternate device 
for ETT. 
 
Haemodynamic responses 
The smoother, thin wedge shaped cuff bowl allows comfortable insertion, good 
airway tolerance and smoother emergence. It resulted in less change in heart 
rate, SBP, DBP and MAP after insertion. Vila et al
2
 observed similar 
haemodynamic conditions in their study. The intubation response to ETT is well 
known and this can be overcome by employing LMA-Supreme as an 
alternative. 
 Blood staining 
The smoother and easier insertion observed with LMA-Supreme results in less 
airway trauma. The drain tube by facilitating easier insertion of gastric tube also 
reduces the chances of airway injury. In our study blood staining was noted in 
6.7% patients with LMA-S. Tan et al
17
, Seet et al
18
, Lopez et al
27
 evaluated the 
efficacy of LMA-S and found similar incidences of blood staining.  
 
Incidence of complications 
The unique design of LMA-Supreme makes it a pharyngolaryngeal sparing 
strategy. Abdi et al
1
 showed lesser incidence of sore throat and hoarseness 
compared to ETT. In our study none of the patients in LMA-S group 
complained of sore throat and hoarseness of voice against 9/30 and 8/30, 
respectively in ETT group. The difference is significant, thus incidence of 
complications is less with LMA-S. Tan et al
17
, Kohama et al
25
, Seet et al
18
 
showed reduced incidences of pharyngo laryngeal discomfort. 
 
The LMA-Supreme has the advantage of being a single-use device. There is an 
increased tendency towards single-use devices due to the awareness that protein 
and bacteria persist on surgical and anaesthetic instruments following 
decontamination and sterilisation. Being a single use device it can reduce or 
even eliminate this problem. 
 
Our study has certain limitations. First, we studied a female population with 
normal airways undergoing elective laparoscopic gynaecological surgeries. The 
data collected cannot be directly extrapolated to the use of LMA-Supreme in 
males. Second, blinding was not practically possible, which may be a possible 
source of bias. Finally, being a single-use device the cost effectiveness was not 
addressed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 SUMMARY 
 
From this Prospective, Randomised, Comparative single blinded case control 
study which evaluated the effectiveness of LMA-S and ETT, it is found that, 
 
 Both LMA-S and ETT were intubated with similar ease (P = 0.314). 
 
 Number of attempts required for successful insertion of LMA-S was more 
than that of ETT but not statistically significant.  
 
 Time taken for insertion of LMA-S was lesser than ETT, which is 
statistically significant (P <0.001). 
 
 Ease of insertion of Gastric tube with LMA-S was better than that of 
ETT, which is statistically significant (P = 0.005) 
 
 Number of attempts required for successful insertion of gastric tube was 
lesser with LMA-S than with ETT but not statistically significant.  
 
 No significant gastric distension occurred intra operatively with both 
LMA-S and ETT. So, LMA-S provides good oropharyngeal seal and 
pulmonary ventilation. 
 Both the techniques had no significant differences in SpO2 and EtCO2 
before inflation, after inflation and after deflation. Thus LMA-S is also a 
good airway device for laparoscopic surgeries. 
 
 Haemodynamically there was a significant difference between two groups 
with regard to heart rate, systolic blood pressure, diastolic blood pressure 
and mean arterial pressure after insertion. LMA-S was found to be a 
better device in this aspect. 
 
 Blood staining on LMA-S and ETT were comparable and was not 
statistically significant. 
 
 Incidence of post operative sore throat and hoarseness of voice was less 
with LMA-S than with ETT and was statistically significant.  
 
 
 
 
 
 
  
 CONCLUSION 
 
LMA-Supreme is an equally effective airway device to ETT in laparoscopic 
gynaecological surgeries. It has potential advantages like rapid placement, less 
haemodynamic response, less airway trauma, less pharyngolaryngeal morbidity 
and better oesophageal seal resulting in reduced risk of gastric distension and 
aspiration. 
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 PATIENT CONSENT FORM 
 
 
Study title        :           Prospective comparison of LMA-Supreme and Endotracheal Tube in 
Elective  
                                     Laparoscopic Gynaecological Surgeries.  
. 
                                        
Study centre    :           Department of Anaesthesiology, 
                                    Govt. Kasturba Gandhi Hospital for Women and Children, Chennai. 
 
 
Participant name :                                                Age:                         Sex:                                
I.P.No: 
 
                  
                        I confirm that I have understood the purpose of procedure for the above study. 
I have the opportunity to ask the question and all my questions and doubts have been 
answered to my satisfaction. 
                      
                        I have been explained about the pitfall in the procedure. I have been explained 
about the safety, advantage and disadvantage of the technique.  
 
                        I understand that my participation in the study is voluntary and that i am free 
to withdraw at anytime without giving any reason.  
 
                        I understand that the investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records both in respect to current 
study and any further research that may be conducted in relation to it, even if i withdraw from 
the study. I understand that my identity will not be revealed in any information released to the 
third parties or published, unless as required under the law . I agree not to restrict the use of 
any data or results that arise from the study.  
 
Time:          
 
Date:                                                                                 signature / thumb impression of 
Patient 
 
Place:                                                                                Patient name: 
 
Signature of the investigator: 
 
Name of the investigator: 
 
 
 PROFORMA 
DATE:                                     ROLL NO:                                                   AIRWAY DEVICE: 
NAME:                                                      AGE:                                                            SEX:                    
IP NO:                                                       DIAGNOSIS:                                               SURGICAL PROCEDURE DONE: 
Ht:                                                                       CVS:                                 HB: 
Wt:                                                                       RS: 
AIRWAY:           MMC -                                                         IID      -                                               DENTITION -                      
PRE OP ASSESSMENT:                ASA I   /    ASA II 
HISTORY:    Any Co-morbid illness 
                     H/O Documented Difficult Airway 
                      H/O previous surgeries 
MEASURES OF STUDY OUTCOME: 
1) INTUBATION RESPONSE:                                                                                  5)     ENDTIDAL CO2      
                                             HR           SBP            DBP         MAP        SPO2                         
PRE OP:                                                                                                                                  BASELINE:                                                                                            
PRE INTUBATION:                                                                                                              POST INFLATION: 
POST INTUBATION:                                                                                                            POST DEFLATION: 
1 MIN: 
3 MIN: 
5 MIN: 
2)  AIRWAY DEVICE 
EASE OF INSERTION:              EASY                                                  DIFFICULT 
NO OF ATTEMPTS: 
INSERTION TIME: 
3) GASTRIC TUBE: 
EASE OF INSERTION:                  EASY                                                  DIFFICULT 
NO OF ATTEMPTS :                                                                            GASTRIC DISTENSION: 
4) COMPLICATIONS AT EXTUBATION: 
POST OP SORE THROAT: 
LARYNGOSPASM: 
BLOOD STAINING OF AIRWAY DEVICE: 
HOARESNESS  OF VOICE: 
 
.  
S.NO NAME AGE DEVICE BMI ASA MPC 
AD OGT COMPLICATION 
EOI NOA TTI EOI NOA GD ST LS BS HV 
1 HAMSA 27 LMA-S 21.6 I I E 1 15 E 1 0 N N Y N 
2 MAHALAKSHMI 37 LMA-S 22.5 I I E 1 12 E 1 1 N N N N 
3 ELAVARASI 28 LMA-S 26.5 II I E 1 16 E 1 0 N N N N 
4 GUNA 24 LMA-S 21.5 I II E 1 12 E 1 0 N N N N 
5 PUSHPA 22 LMA-S 20.4 I I E 1 13 E 1 0 N N N N 
6 SATHIYA 29 LMA-S 22.2 I II E 1 15 E 1 0 N N N N 
7 RAJALAKSHMI 31 LMA-S 24.9 I II E 1 14 E 1 1 N N N N 
8 UMA 31 LMA-S 21.5 II I E 1 16 E 1 2 N N N N 
9 REKHA 22 LMA-S 23.5 I II D 2 25 E 1 1 N Y Y N 
10 PREMASHEELA 29 LMA-S 23.3 II I E 1 19 E 1 1 N N N N 
11 DEEPA 23 LMA-S 24.1 I I E 1 16 E 1 0 N N N N 
12 DHAVAMANI 36 LMA-S 22.8 I I E 1 13 E 1 0 N N N N 
13 SELVAMUTHA 26 LMA-S 21.9 I I E 1 13 E 1 0 N N N N 
14 PARIMALA 21 LMA-S 22 I I E 1 17 E 1 0 N N N N 
15 RENUKADEVI 24 LMA-S 23.4 I I E 1 16 E 1 1 N N N N 
16 SUBITHA 35 LMA-S 26 I II E 1 15 E 1 2 N N N N 
17 GEETHA 19 LMA-S 22.4 I I E 1 12 E 1 1 N N N N 
18 SUGANTHY 30 LMA-S 25 I II E 1 18 E 1 1 N N N N 
19 DESAM 30 LMA-S 21.1 I II E 1 12 E 1 0 N N N N 
20 SEETHA 27 LMA-S 23.7 I I E 1 13 E 1 0 N N N N 
21 SHANKARI 32 LMA-S 21.3 I I E 1 15 E 1 0 N N N N 
22 SUGANTHA 24 LMA-S 23.6 I I E 1 14 E 1 0 N N N N 
23 DURGALAKSHMI 31 LMA-S 24.6 I I E 1 16 E 1 0 N N N N 
24 SARGUNAM 32 LMA-S 27.3 I I E 1 17 E 1 0 N N N N 
25 BANU 53 LMA-S 23.5 I I E 1 19 E 1 0 N N N N 
26 KAMATCHI 26 LMA-S 22.2 I I E 1 16 E 1 1 N N N N 
27 JEYALAKSHMI 35 LMA-S 23.4 II II E 1 14 E 1 0 N N N N 
28 DHANALAKSHMI 26 LMA-S 25.1 II I E 1 15 E 1 2 N N N N 
29 SANGEETHA 23 LMA-S 21.9 I II E 1 13 E 1 0 N N N N 
30 SARANYA 20 LMA-S 22.4 I I E 1 15 E 1 0 N N N N 
 
 
 
 
S.NO DEVICE 
SPO2 (%) HEART RATE (beats/min) ETCO2 (mm Hg) 
PRE OP PRE IN POST IN 1 MIN 3 MIN 5 MIN PRE OP PRE IN POST IN 1 MIN 3 MIN 5 MIN BASELINE PI PD 
1 LMA-S 100 100 98 99 100 100 86 85 90 92 92 91 36 38 36 
2 LMA-S 100 100 100 100 100 100 95 86 87 87 85 80 38 39 37 
3 LMA-S 98 100 100 100 100 100 72 74 70 75 68 71 36 38 35 
4 LMA-S 99 98 100 100 100 100 98 90 90 85 80 76 37 39 38 
5 LMA-S 100 99 100 100 100 100 110 116 123 115 112 105 38 40 36 
6 LMA-S 100 98 100 100 100 100 95 112 110 105 109 98 38 40 38 
7 LMA-S 100 99 100 100 100 100 86 80 96 95 83 86 37 38 36 
8 LMA-S 100 100 100 100 100 100 79 82 81 84 73 75 37 41 39 
9 LMA-S 100 100 100 100 100 100 122 126 125 116 110 102 36 38 37 
10 LMA-S 100 100 100 100 100 100 88 85 95 94 82 82 39 40 38 
11 LMA-S 97 100 99 99 100 100 92 92 80 80 75 70 37 40 38 
12 LMA-S 98 100 98 99 100 100 94 90 85 83 86 89 37 39 38 
13 LMA-S 99 100 98 99 99 100 109 112 120 122 109 105 38 41 37 
14 LMA-S 99 100 100 100 99 100 116 115 119 107 105 102 37 39 36 
15 LMA-S 100 100 100 99 100 100 116 100 102 83 89 99 37 40 41 
16 LMA-S 100 100 100 100 99 100 82 86 89 85 88 89 36 38 36 
17 LMA-S 100 100 100 100 100 100 90 92 100 93 95 100 38 39 39 
18 LMA-S 100 100 100 100 100 100 116 82 106 91 99 112 36 38 37 
19 LMA-S 100 100 100 100 100 100 105 85 83 90 94 86 38 37 35 
20 LMA-S 100 100 99 99 100 99 96 75 82 86 84 89 36 38 36 
21 LMA-S 99 100 99 100 100 100 112 90 115 110 96 80 38 43 40 
22 LMA-S 99 99 99 100 99 100 93 82 91 85 86 73 37 38 36 
23 LMA-S 100 100 98 100 100 100 89 86 89 79 76 92 37 41 40 
24 LMA-S 99 98 99 100 100 100 82 68 68 72 75 70 36 37 36 
25 LMA-S 100 100 100 99 100 100 119 90 100 101 95 93 37 39 35 
26 LMA-S 98 100 100 100 100 100 102 86 90 93 91 85 37 38 36 
27 LMA-S 98 100 100 100 100 100 81 65 69 75 71 78 36 39 37 
28 LMA-S 100 100 100 100 100 100 110 91 96 89 85 86 37 38 37 
29 LMA-S 100 100 100 100 100 100 95 86 88 75 79 75 36 39 36 
30 LMA-S 100 100 100 100 100 100 104 95 94 99 89 85 36 39 36 
 
  
S.NO DEVICE 
PRE OP PRE IN POST IN 1 MIN 3 MIN 5 MIN 
SBP DBP MAP SBP DBP MAP SBP DBP MAP SBP DBP MAP SBP DBP MAP SBP DBP MAP 
1 LMA-S 128 76 93 96 69 78 100 60 73 107 65 79 108 72 84 107 70 82 
2 LMA-S 133 85 101 102 63 76 110 69 83 105 62 76 111 69 83 106 65 78 
3 LMA-S 116 83 94 98 56 70 109 68 82 115 65 81 119 79 92 115 71 85 
4 LMA-S 145 92 109 113 69 84 115 68 84 114 72 86 116 59 78 110 61 77 
5 LMA-S 105 76 85 86 60 69 90 61 71 95 68 77 100 72 81 101 70 80 
6 LMA-S 112 65 80 95 64 74 96 68 77 102 71 81 108 75 86 105 68 80 
7 LMA-S 124 89 101 106 59 75 117 68 84 116 75 88 116 80 92 114 76 88 
8 LMA-S 118 86 96 101 69 80 105 63 77 109 65 79 110 63 78 110 65 80 
9 LMA-S 120 80 93 80 61 67 93 65 74 99 72 81 97 56 69 99 63 75 
10 LMA-S 96 72 80 86 65 72 93 68 76 99 65 76 100 60 73 99 75 83 
11 LMA-S 121 80 94 90 50 63 103 41 62 105 58 73 97 52 67 100 56 70 
12 LMA-S 136 89 105 105 65 78 112 72 85 109 68 81 105 72 83 96 63 74 
13 LMA-S 99 56 70 82 51 61 101 62 75 113 72 85 116 72 86 110 76 87 
14 LMA-S 130 90 103 91 52 65 103 60 74 93 52 65 96 58 70 95 60 71 
15 LMA-S 135 77 96 81 58 66 95 65 75 94 56 68 99 61 73 101 65 77 
16 LMA-S 124 84 97 94 72 79 100 62 75 93 61 72 100 69 79 110 65 80 
17 LMA-S 120 80 93 90 60 70 92 46 61 94 50 64 99 56 70 105 60 75 
18 LMA-S 121 72 88 85 46 59 149 59 89 108 58 74 115 64 81 112 66 81 
19 LMA-S 145 96 112 119 82 94 115 79 91 116 76 89 112 73 86 110 69 82 
20 LMA-S 133 94 107 114 81 92 125 81 96 122 74 90 118 70 86 115 65 81 
21 LMA-S 115 81 92 99 53 68 115 72 86 110 75 87 112 77 88 111 73 85 
22 LMA-S 126 85 99 102 59 73 119 73 88 121 75 91 120 72 88 113 69 83 
23 LMA-S 118 75 89 98 68 78 110 75 87 125 78 94 122 65 84 120 65 83 
24 LMA-S 114 81 92 90 56 67 95 53 67 99 62 74 92 65 74 95 64 74 
25 LMA-S 126 95 105 111 78 89 114 80 92 113 85 94 116 82 93 112 73 86 
26 LMA-S 106 75 85 91 63 72 100 71 84 106 75 85 108 72 84 110 65 80 
27 LMA-S 110 81 91 96 64 75 97 60 73 101 64 76 99 63 75 98 65 76 
28 LMA-S 135 82 100 112 64 80 119 68 85 128 72 90 121 76 91 125 74 91 
29 LMA-S 122 81 95 100 73 82 110 76 87 112 74 86 116 70 85 114 68 83 
30 LMA-S 137 84 102 115 79 91 112 64 80 110 69 82 114 70 84 113 69 83 
 
  
S.NO NAME AGE DEVICE BMI ASA MPC 
AD NGT COMPLICATION 
EOI NOA TTI EOI NOA GD ST LS BS HV 
1 MEENA 27 ETT 22.3 I I E 1 22 E 1 0 N N N N 
2 UMA 33 ETT 21.6 I II E 1 24 D 1 0 N N N N 
3 SARANYA 20 ETT 24.5 I I E 1 25 E 1 0 N N N Y 
4 KALAISELVI 28 ETT 21.5 I I E 1 21 E 1 0 Y N N N 
5 POONGODI 25 ETT 22.8 I I E 1 21 E 1 2 N N N N 
6 KANAGA 22 ETT 23.4 I I E 1 20 E 1 1 Y N N N 
7 PANJALAI 29 ETT 26.5 II I E 1 26 E 1 3 N N N N 
8 JANANI 26 ETT 21 I II E 1 24 D 2 0 N N N N 
9 NAJMA 35 ETT 9 II I E 1 23 E 1 0 N N N N 
10 SUJATHA 30 ETT 20.9 I I E 1 26 E 1 0 Y N N Y 
11 VICTORIA 19 ETT 24.1 II I E 1 26 D 1 5 Y N N N 
12 KUMUTHA 28 ETT 25 I II E 1 31 E 1 1 Y N N Y 
13 KANAGAVALLI 30 ETT 23.8 I I E 1 27 E 1 0 N N N N 
14 DHATCHAYINI 25 ETT 23.7 I I E 1 22 D 1 0 N N N N 
15 MALATHI 30 ETT 24.6 II I E 1 26 E 1 1 N N N N 
16 SANGARESHWARI 36 ETT 22.5 I I E 1 23 D 2 0 Y N N N 
17 BHAVANI 27 ETT 22.8 I I E 1 25 E 1 0 N N N Y 
18 SUDHA 35 ETT 21.9 I II E 1 26 D 2 0 Y N N Y 
19 KRITHIKA 22 ETT 20.6 I II E 1 22 E 1 1 N N N N 
20 ANBARASI 26 ETT 26 I II E 1 27 E 1 0 N N N Y 
21 DEVIKA 30 ETT 21.9 II I E 1 28 E 1 0 N N N N 
22 RAJESWARI 32 ETT 25.4 I I E 1 23 E 1 0 N N N N 
23 SASIKALA 33 ETT 22.3 I II E 1 24 E 1 0 N N N N 
24 NASREEN 24 ETT 24 I I E 1 29 E 1 0 N N N Y 
25 NASEEMA 24 ETT 21.6 II I E 1 26 E 1 3 N N N N 
26 BHARATHI 20 ETT 23.4 I II E 1 24 D 1 0 N N N N 
27 VARALAKSHMI 34 ETT 22.9 I II E 1 28 E 1 0 N N N N 
28 TAMILSELVI 28 ETT 22.8 I I E 1 23 E 1 0 Y N N Y 
29 VAIJEYANTHI 38 EET 23.1 I I E 1 25 E 1 0 N N N N 
30 SHAKILA 30 EET 23 I I E 1 26 E 1 2 Y N N N 
 
  
S.NO DEVICE 
SPO2 (%) HEART RATE (beats/min) ETCO2 (mm Hg) 
PREOP PRE IN POST IN 1 MIN 3 MIN 5 MIN PRE OP PRE IN POST IN 1 MIN 3 MIN 5 MIN 
BASELI
NE 
PI PD 
1 ETT 100 100 99 99 100 100 80 78 96 94 82 85 39 42 40 
2 ETT 99 100 100 100 100 100 102 105 116 112 113 112 36 45 42 
3 ETT 100 100 99 100 99 99 84 86 94 90 83 86 38 38 41 
4 ETT 99 99 99 100 100 100 91 95 106 105 101 95 35 36 35 
5 ETT 100 100 100 100 100 100 81 86 93 91 92 89 34 38 37 
6 ETT 100 99 98 99 99 99 118 116 121 120 115 101 39 39 36 
7 ETT 98 100 100 100 100 100 122 125 136 130 120 121 36 44 40 
8 ETT 98 99 100 100 99 100 88 80 100 80 85 90 39 42 36 
9 ETT 99 100 100 100 100 100 85 89 99 96 92 91 37 40 38 
10 ETT 100 100 100 100 100 99 84 82 100 96 98 89 36 39 37 
11 ETT 100 100 99 100 99 100 69 68 73 75 72 69 36 41 40 
12 ETT 100 100 100 100 100 100 96 94 99 96 90 95 38 39 35 
13 ETT 100 100 100 100 100 100 90 95 99 92 92 98 34 38 39 
14 ETT 100 100 100 100 99 100 85 83 100 102 102 96 36 39 36 
15 ETT 100 100 100 100 100 100 106 105 116 115 98 107 37 35 38 
16 ETT 100 100 99 99 100 99 96 91 106 101 89 98 39 36 37 
17 ETT 99 100 100 100 100 99 108 98 120 116 118 112 38 37 40 
18 ETT 100 99 100 100 100 100 85 89 99 94 92 86 39 41 40 
19 ETT 100 100 100 100 99 100 75 79 81 85 80 76 35 36 39 
20 ETT 100 100 100 100 100 100 110 115 127 124 126 123 36 39 38 
21 ETT 100 100 100 100 100 99 76 79 89 88 84 82 38 38 36 
22 ETT 99 99 99 99 100 100 92 85 106 99 95 91 38 35 40 
23 ETT 99 100 98 100 100 100 90 90 99 96 94 92 37 42 38 
24 ETT 100 100 99 100 100 100 89 89 96 96 91 86 36 39 37 
25 ETT 100 99 100 100 100 100 122 125 131 129 116 117 38 36 39 
26 ETT 100 100 100 100 100 99 80 76 92 90 86 79 39 42 38 
27 ETT 100 100 100 100 100 100 99 98 115 112 106 104 36 36 36 
28 ETT 100 100 100 100 99 100 80 82 95 94 89 86 38 43 38 
29 ETT 100 100 100 100 100 100 95 88 98 97 91 89 36 39 38 
30 ETT 100 100 99 100 100 100 116 114 124 120 119 116 38 38 35 
 
  
S.NO DEVICE 
PRE OP PRE IN POST IN 1 MIN 3 MIN 5 MIN 
SBP DBP MAP SBP DBP MAP SBP DBP MAP SBP DBP MAP SBP DBP MAP SBP DBP MAP 
1 ETT 121 78 92 103 72 82 109 76 87 106 75 85 110 76 87 111 75 87 
2 ETT 132 85 100 116 73 87 129 81 97 125 80 95 126 89 101 124 86 98 
3 ETT 113 75 87 100 65 76 111 71 84 115 72 86 116 78 90 115 76 89 
4 ETT 121 84 96 108 72 84 126 84 98 129 85 99 130 80 96 129 81 97 
5 ETT 113 65 81 96 72 80 112 89 96 114 84 94 113 82 92 110 79 89 
6 ETT 106 72 83 86 61 69 99 63 75 98 69 78 110 75 86 107 75 85 
7 ETT 120 80 93 103 71 81 116 75 88 120 72 88 130 80 96 126 76 92 
8 ETT 104 70 81 90 61 70 117 67 83 108 70 82 129 79 96 121 85 97 
9 ETT 131 91 104 109 72 84 129 73 91 125 71 89 126 76 92 125 78 93 
10 ETT 126 81 96 103 69 80 115 81 92 114 73 86 115 75 88 116 72 86 
11 ETT 117 69 85 109 65 79 121 72 88 125 73 90 124 71 87 124 68 86 
12 ETT 118 76 90 106 65 78 123 72 89 125 76 92 121 71 88 120 72 88 
13 ETT 106 65 78 85 59 67 96 72 80 95 76 82 100 76 84 102 75 84 
14 ETT 103 71 81 82 56 64 95 71 79 98 72 80 100 72 81 99 63 75 
15 ETT 117 68 84 91 59 69 102 68 79 105 63 77 100 65 76 101 68 79 
16 ETT 126 81 96 103 65 77 116 72 86 115 73 87 117 75 89 119 75 89 
17 ETT 102 75 84 81 56 64 92 61 71 94 65 74 98 64 75 95 69 77 
18 ETT 96 72 80 84 56 65 93 71 78 94 72 79 96 72 80 98 73 81 
19 ETT 131 82 98 113 75 87 126 81 96 124 86 98 125 80 95 124 82 96 
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PROSPECTIVE RANDOMISED COMPARISION OF LMA-SUPREME AND 
ENDOTRACHEAL TUBE IN ELECTIVE LAPAROSCOPIC GYNAECOLOGICAL 
SURGERIES 
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ABSTRACT 
BACKGROUND: The Laryngeal Mask Airway Supreme (LMA-S)  is a new supraglottic airway 
incorporating features of the LMA-Proseal, LMA Fastrach and LMA Unique. We designed a 
prospective, randomised, single blind case control study to evaluate the advantages and 
disadvantages of LMA-Supreme over Endotracheal tube (ETT) for general anesthesia in 
laparoscopic gynaecological surgeries. We compared the insertion conditions, adequacy of 
ventilation and incidence of complications. 
METHODS: After obtaining institutional ethics committee approval, sixty ASA PS I & II adult 
patients undergoing elective laparoscopic gynaecological surgeries were randomised to receive 
either the LMA-S or ETT for airway management. Anaesthesia was induced with 
propofol/fentanyl/atracurium, maintained with sevoflurane/atracurium and IPPV. Ease of 
insertion, No. of attempts required for successful insertion, time taken for insertion, ease of 
gastric tube insertion, haemodynamic changes, EtCO
2
,  blood staining of device and post 
operative sore throat/hoarseness of voice were recorded. 
RESULTS: Both the devices were inserted with similar ease (96.7% in LMA-S vs 100% in 
ETT). The first attempt success rate of insertion was similar in both groups, 96.7% in LMA-S vs 
100% in ETT. The effective airway was established rapidly with LMA-S compared to ETT (15.2 
vs 24.7 seconds, respectively P < 0.01). Gastric tube insertion was easier with LMA-S than ETT 
(100% vs 76.7%, respectively). The intubation was smooth with less haemodynamic response in 
LMA-S group. The incidence of sore throat and hoarseness of voice was less in LMA-S group, 
with P value of 0.001and 0.002, respectively. 
CONCLUSION: We concluded LMA-Supreme as an equally effective airway device to ETT in 
laparoscopic gynaecological surgeries with potential advantages of rapid placement, less 
haemodynamic response, less airway trauma, less postoperative pharyngolaryngeal morbidity 
and better oesophageal seal preventing risk of gastric distension and aspiration. 
KEY WORDS: LMA-Supreme, Endotracheal tube, Laparoscopic gynaecological surgeries 
